These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36482462)

  • 1. Role of the occupational disease consultant in the multidisciplinary discussion of interstitial lung diseases.
    Carlier S; Nasser M; Fort E; Lamouroux C; Si-Mohamed S; Chalabreysse L; Maury JM; Diesler R; Cottin V; Charbotel B
    Respir Res; 2022 Dec; 23(1):332. PubMed ID: 36482462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive assessment of environmental exposures and the medical history guides multidisciplinary discussion in interstitial lung disease.
    Dodia N; Amariei D; Kenaa B; Corwin D; Chelala L; Britt EJ; Sachdeva A; Luzina IG; Hasday JD; Shah NG; Atamas SP; Franks TJ; Burke AP; Hines SE; Galvin JR; Todd NW
    Respir Med; 2021 Apr; 179():106333. PubMed ID: 33676119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chinese expert consensus on multidisciplinary discussion of interstitial lung disease].
    ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Dec; 46(12):1176-1188. PubMed ID: 37989522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
    Hyldgaard C
    Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Ability of a Dynamic Multidisciplinary Discussion in Interstitial Lung Diseases: A Retrospective Observational Study of 938 Cases.
    De Sadeleer LJ; Meert C; Yserbyt J; Slabbynck H; Verschakelen JA; Verbeken EK; Weynand B; De Langhe E; Lenaerts JL; Nemery B; Van Raemdonck D; Verleden GM; Wells AU; Wuyts WA
    Chest; 2018 Jun; 153(6):1416-1423. PubMed ID: 29608882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and prognosis of unclassifiable interstitial lung disease.
    Ryerson CJ; Urbania TH; Richeldi L; Mooney JJ; Lee JS; Jones KD; Elicker BM; Koth LL; King TE; Wolters PJ; Collard HR
    Eur Respir J; 2013 Sep; 42(3):750-7. PubMed ID: 23222877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact of the interstitial lung disease multidisciplinary service.
    Jo HE; Glaspole IN; Levin KC; McCormack SR; Mahar AM; Cooper WA; Cameron R; Ellis SJ; Cottee AM; Webster SE; Troy LK; Torzillo PJ; Corte P; Symons KM; Taylor N; Corte TJ
    Respirology; 2016 Nov; 21(8):1438-1444. PubMed ID: 27427515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of an interstitial lung disease service in the diagnosis and management of interstitial lung disease in Singapore.
    Chai GT; Tan TC; Lee YS; Kaw GJ; Chuah KL; Lim YJ; Abisheganaden JA; Thong BY
    Singapore Med J; 2020 Jun; 61(6):302-307. PubMed ID: 31317200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unclassifiable interstitial lung disease: from phenotyping to possible treatments.
    Guler SA; Ryerson CJ
    Curr Opin Pulm Med; 2018 Sep; 24(5):461-468. PubMed ID: 30004990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Multidisciplinary Discussion (MDD) in the Diagnosis and Management of Fibrotic Interstitial Lung Diseases.
    Ageely G; Souza C; De Boer K; Zahra S; Gomes M; Voduc N
    Can Respir J; 2020; 2020():9026171. PubMed ID: 32879642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature.
    Ferri C; Manfredi A; Sebastiani M; Colaci M; Giuggioli D; Vacchi C; Della Casa G; Cerri S; Torricelli P; Luppi F
    Autoimmun Rev; 2016 Jan; 15(1):61-70. PubMed ID: 26384526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unclassifiable interstitial lung disease: A review.
    Skolnik K; Ryerson CJ
    Respirology; 2016 Jan; 21(1):51-6. PubMed ID: 26059704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interstitial Lung Disease in India. Results of a Prospective Registry.
    Singh S; Collins BF; Sharma BB; Joshi JM; Talwar D; Katiyar S; Singh N; Ho L; Samaria JK; Bhattacharya P; Gupta R; Chaudhari S; Singh T; Moond V; Pipavath S; Ahuja J; Chetambath R; Ghoshal AG; Jain NK; Devi HJ; Kant S; Koul P; Dhar R; Swarnakar R; Sharma SK; Roy DJ; Sarmah KR; Jankharia B; Schmidt R; Katiyar SK; Jindal A; Mangal DK; Singh V; Raghu G
    Am J Respir Crit Care Med; 2017 Mar; 195(6):801-813. PubMed ID: 27684041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis.
    Fisher JH; Kolb M; Algamdi M; Morisset J; Johannson KA; Shapera S; Wilcox P; To T; Sadatsafavi M; Manganas H; Khalil N; Hambly N; Halayko AJ; Gershon AS; Fell CD; Cox G; Ryerson CJ
    BMC Pulm Med; 2019 Nov; 19(1):223. PubMed ID: 31771541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidisciplinary management of interstitial lung diseases: A real-life study.
    Biglia C; Ghaye B; Reychler G; Koenig S; Yildiz H; Lacroix V; Tamirou F; Hoton D; Pieters T; Froidure A
    Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(2):108-115. PubMed ID: 32476943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges in the diagnosis of idiopathic pulmonary fibrosis: the importance of a multidisciplinary approach.
    Comes A; Sgalla G; Ielo S; Magrì T; Richeldi L
    Expert Rev Respir Med; 2023 Apr; 17(4):1-11. PubMed ID: 37005289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative incidence of interstitial lung diseases in Brazil.
    Matias SLK; Pereira CAC; Soares MR; Fernandes FCV; Moreira MAC; Baptista FMA; Prata TA; Cordeiro Junior G; Mancuzo EV
    J Bras Pneumol; 2024; 50(1):e20230232. PubMed ID: 38536981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cohort study of interstitial lung diseases in central Denmark.
    Hyldgaard C; Hilberg O; Muller A; Bendstrup E
    Respir Med; 2014 May; 108(5):793-9. PubMed ID: 24636811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interstitial Lung Diseases in Developing Countries.
    Rivera-Ortega P; Molina-Molina M
    Ann Glob Health; 2019 Jan; 85(1):. PubMed ID: 30741505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-life prevalence of progressive fibrosing interstitial lung diseases.
    Gagliardi M; Berg DV; Heylen CE; Koenig S; Hoton D; Tamirou F; Pieters T; Ghaye B; Froidure A
    Sci Rep; 2021 Dec; 11(1):23988. PubMed ID: 34907290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.